Folinic acid plus high-dose 5-fluorouracil with allopurinol protection in the treatment of advanced colorectal carcinoma
- 1 January 1990
- journal article
- clinical trial
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 26 (10) , 1054-1056
- https://doi.org/10.1016/0277-5379(90)90050-4
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Concomitant Administration of 4-Hydroxypyrazolopyrimidine (Allopurinol) and High-Dose Continuous Infusion 5-FluorouracilOncology, 1990
- Fluorouracil: biochemistry and pharmacology.Journal of Clinical Oncology, 1988
- Effect of perioperative blood loss and perioperative blood transfusions on colorectal cancer survivalEuropean Journal of Cancer and Clinical Oncology, 1988
- High-dose folinic acid (HDFA) combined with 5-fluorouracil (5-FU) in first line chemotherapy of advanced large bowel cancerEuropean Journal of Cancer and Clinical Oncology, 1987
- Failure of Allopurinol to Provide Clinically Significant Protection against the Hematologic Toxicity of a Bolus 5-FU ScheduleOncology, 1986
- Phase II Trial of High-Dose Continuous Infusion 5-Fluorouracil with Allopurinol Modulation in Colon CancerOncology, 1986
- 5-Fluorouracil and Folinic Acid: a Phase I–II trial in gastrointestinal malignancyInvestigational New Drugs, 1984
- Effect of allopurinol on the toxicity of high-dose 5-fluorouracil administered by intermittent bolus injectionCancer, 1983
- EFFECT OF BLOOD TRANSFUSIONS ON COLONIC MALIGNANCY RECURRENCE RATEThe Lancet, 1982
- Reporting results of cancer treatmentCancer, 1981